Terms: = Prostate cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474
56 results:
1. FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in prostate cancer.
Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
[TBL] [Abstract] [Full Text] [Related]
2. ARPC5 is transcriptionally activated by klf4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
Qu G; Zhang Y; Duan H; Tang C; Yang G; Chen D; Xu Y
Apoptosis; 2023 Jun; 28(5-6):783-795. PubMed ID: 36881291
[TBL] [Abstract] [Full Text] [Related]
3. Paternity through use of assisted reproduction technology in male adult and childhood cancer survivors: a nationwide register study.
Kitlinski M; Giwercman A; Elenkov A
Hum Reprod; 2023 May; 38(5):973-981. PubMed ID: 36773319
[TBL] [Abstract] [Full Text] [Related]
4. IGT mediated Nanog siRNA delivery in prostate cancer cells improves chemosensitization of Epirubicin in vitro.
Gupta S; Das U; Sinha S
Bioorg Med Chem Lett; 2022 Nov; 76():129017. PubMed ID: 36209968
[TBL] [Abstract] [Full Text] [Related]
5. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
6. Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers.
Thomas E; Thankan RS; Purushottamachar P; Huang W; Kane MA; Zhang Y; Ambulos N; Weber DJ; Njar VCO
Mol Carcinog; 2022 Jul; 61(7):643-654. PubMed ID: 35512605
[TBL] [Abstract] [Full Text] [Related]
7. Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer.
Chodary Khameneh S; Razi S; Shamdani S; Uzan G; Naserian S
Sci Rep; 2022 Feb; 12(1):2990. PubMed ID: 35194111
[TBL] [Abstract] [Full Text] [Related]
8. Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.
Vélot L; Lessard F; Bérubé-Simard FA; Tav C; Neveu B; Teyssier V; Boudaoud I; Dionne U; Lavoie N; Bilodeau S; Pouliot F; Bisson N
Mol Cell Proteomics; 2021; 20():100064. PubMed ID: 33640491
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer.
Jiang M; Cheng Y; Wang D; Lu Y; Gu S; Wang C; Huang Y; Li Y
EBioMedicine; 2021 Jan; 63():103150. PubMed ID: 33279858
[TBL] [Abstract] [Full Text] [Related]
10. Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common cancer Types.
Taracha-Wisniewska A; Kotarba G; Dworkin S; Wilanowski T
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266506
[TBL] [Abstract] [Full Text] [Related]
11. miR-1: A comprehensive review of its role in normal development and diverse disorders.
Safa A; Bahroudi Z; Shoorei H; Majidpoor J; Abak A; Taheri M; Ghafouri-Fard S
Biomed Pharmacother; 2020 Dec; 132():110903. PubMed ID: 33096351
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure.
Prajapati A; Chauhan G; Shah H; Gupta S
J Trace Elem Med Biol; 2020 Dec; 62():126633. PubMed ID: 32818862
[TBL] [Abstract] [Full Text] [Related]
13. Reprogramming prostate cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of prostate cancer Stem Cell Research.
Zhang Y; Chen B; Xu P; Liu C; Huang P
Cell Reprogram; 2020 Oct; 22(5):262-268. PubMed ID: 32816532
[TBL] [Abstract] [Full Text] [Related]
14. Roles of OCT4 in pathways of embryonic development and cancer progression.
Patra SK
Mech Ageing Dev; 2020 Jul; 189():111286. PubMed ID: 32531293
[TBL] [Abstract] [Full Text] [Related]
15. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing klf4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract] [Full Text] [Related]
17. klf4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone.
Tassone E; Bradaschia-Correa V; Xiong X; Sastre-Perona A; Josephson AM; Khodadadi-Jamayran A; Melamed J; Bu L; Kahler DJ; Ossowski L; Leucht P; Schober M; Wilson EL
Oncogene; 2019 Jul; 38(29):5766-5777. PubMed ID: 31239516
[TBL] [Abstract] [Full Text] [Related]
18. miR-148-3p and miR-152-3p synergistically regulate prostate cancer progression via repressing klf4.
Feng F; Liu H; Chen A; Xia Q; Zhao Y; Jin X; Huang J
J Cell Biochem; 2019 Oct; 120(10):17228-17239. PubMed ID: 31104329
[TBL] [Abstract] [Full Text] [Related]
19. Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells.
Lee SI; Roney MSI; Park JH; Baek JY; Park J; Kim SK; Park SK
Prostate; 2019 May; 79(7):720-731. PubMed ID: 30816566
[TBL] [Abstract] [Full Text] [Related]
20. Generation of human iPSCs from fetal prostate fibroblasts HPrF.
Kahounová Z; Slabáková E; Binó L; Remšík J; Fedr R; Bouchal J; Vrtěl R; Jurečková L; Porokh V; Páralová D; Hampl A; Souček K
Stem Cell Res; 2019 Mar; 35():101405. PubMed ID: 30776675
[TBL] [Abstract] [Full Text] [Related]
[Next]
